Inflammatory bowel disease ulcerative colitis

  Inflammatory bowel disease (IBD) is a group of inflammatory diseases of the intestine of unknown origin, characterized by chronic inflammation.
  They include: Crohn’s disease and ulcerative colitis.
  Ulcerative colitis: is a chronic non-specific ulcerative rectal and colitis of unknown etiology.
  Prevalent sites: large intestine, rectum, sigmoid colon;
  Pathological changes: characterized by ulcer formation;
  Clinical manifestations: diarrhea, mucopurulent stools, abdominal pain, urgency and heaviness.
  Distribution: continuous, mucosal and submucosal
  Features: early stage: diffuse fine granular, brittle, easy to bleed; extensive shallow small ulcers
  Late stage: inflammatory polyps, mucosal atrophy, intestinal luminal stenosis, colonic carcinoma
  Histology: inflammatory cell infiltration, intestinal glandular crypt abscess
  Systemic manifestations.
  1. fever Less common, moderate to heavy: low or moderate fever. Fulminant: high fever with systemic toxic symptoms
  2. nutritional disorders, failure, emaciation, anemia, disturbance of water and electricity balance, hypoproteinemia.
  Extra-intestinal manifestations: Eyes: iridocyclitis, uveitis; Mouth: oral ulcers Skin: erythema nodosum, gangrenous pyoderma Joints: pestle and mortar fingers, arthritis Vascular: vasculitis Biliary: sclerosing cholangitis Liver: chronic active hepatitis.
  Most serious complications, mostly fulminant or severe.
  1, mechanism Severe lesions, involving the muscular layer and interosseous nerves from .
  2, causative factors : low potassium, barium enema, anticholinergics or laudanum.
  3, clinical manifestations: toxemia, dehydration, electrolyte disorders; signs: bulging bowel, pressure pain, loss of intestinal sounds; blood count: WBC significantly ↑, abdominal plain film: colon dilatation, disappearance of colonic pouch .
  4. Prognosis is very poor, easy to perforate, high mortality.
  Treatment: control symptoms, reduce recurrence, prevent and control complications
  General treatment
  1.Rest Bed rest, work and rest
  2.Diet During the seizure period – liquid food; in severe cases – fasting
  3, symptomatic treatment abdominal pain, diarrhea, infection, hydropower disorders, anemia, hypoproteinemia
  Drug treatment
  Salicylic acid preparations (preferred)
  (1) Indications: mild and medium-sized patients, heavy hormone therapy in remission: salazosulfapyridine (SASP)
  (2) Drugs Mesalazine : Addisha, Pidexam, Olsalazine
  Indications: For patients with fulminant or heavy disease
  Dosage: oral prednisone 40mg/d
  In severe cases: hydrogen cortisone 200-300mg/d; dexamethasone 10mg/d IV for 7-14 days, change to oral prednisone 60mg/d.